Research programme: Trop-2 targeting aptamer-drug conjugates - Aptamer Sciences/PINOTBIO
Alternative Names: Trop-2 - ApDCLatest Information Update: 04 Dec 2023
At a glance
- Originator Aptamer Sciences; Pinotbio
- Class Antineoplastics; Drug conjugates; Oligonucleotides
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Solid tumours
Most Recent Events
- 01 Dec 2023 Early research in Solid tumours in South Korea (unspecified route) (Aptamer Sciences pipeline, December 2023)